What's new

Human medicines European public assessment report (EPAR): Beqvez (previously Durveqtix), fidanacogene elaparvovec, Date of authorisation: 24/07/2024, Revision: 3, Status: Withdrawn

Human medicines European public assessment report (EPAR): Beqvez (previously Durveqtix), fidanacogene elaparvovec, Date of authorisation: 24/07/2024, Revision: 3, Status: Withdrawn

Jun 5, 2025 - 09:40
 0
Human medicines European public assessment report (EPAR): Beqvez (previously Durveqtix), fidanacogene elaparvovec, Date of authorisation: 24/07/2024, Revision: 3, Status: Withdrawn
Human medicines European public assessment report (EPAR): Beqvez (previously Durveqtix), fidanacogene elaparvovec, Date of authorisation: 24/07/2024, Revision: 3, Status: Withdrawn
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Rivaroxaban Viatris (p...

Next Article

Notes from History for Surviving the Trade War

Related Posts

Human medicines European public assessment report (EPAR): Efficib, sitagliptin,metformin, Date of authorisation: 15/07/2008, Revision: 36, Status: Authorised

Human medicines European public assessment report (EPAR...

May 28, 2025  0

Pegasys

Pegasys

Jun 5, 2025  0

EMEA-003540-PIP01-23

EMEA-003540-PIP01-23

Jun 6, 2025  0